Pfizer Inc Pfizer (NYSE: PFE) and Dren Bio Ink Joint Research/License Agreement Pfizer Inc. (NYSE: PFE) and Dren Bio, Inc both have confirmed that they have inked a joint research/license agreement. This strategic partnership will leverage Dren Bio's proprietary targeted myeloid
